Apheresis has become an important part of modern healthcare by enabling the selective collection, separation, and removal of specific blood components for therapeutic and transfusion-related applications. Unlike conventional blood donation, which typically collects whole blood for subsequent processing, apheresis allows clinicians to target particular components, including plasma, platelets, red blood cells, and white blood cells. This targeted approach supports specialized treatments, improves component collection efficiency, and helps healthcare providers address increasingly complex medical needs. For more information : https://www.pristinemarketinsights.com/apheresis-market-report